Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vital KSK HoldingsTSE:3151 +0.73%69 5-Year Yield-on-Cost % is 19.80 as of Jul. 25, 2026, which is 85% above its 10-year median of 10.69. GuruFocus rates TSE:3151 with a GF Score™ of 69/100 and a GF Value™ of 円1,327.02 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 68 Medical Distribution companies, Vital KSK Holdings ranks better than 98.53% on this metric.
Vital KSK Holdings's yield on cost for the quarter that ended in Mar. 2026 was 19.80.
The historical rank and industry rank for Vital KSK Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:3151'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 6.58 Med: 10.69 Max: 23.4
Current: 19.8
During the past 13 years, Vital KSK Holdings's highest Yield on Cost was 23.40. The lowest was 6.58. And the median was 10.69.
TSE:3151's 5-Year Yield-on-Cost % is ranked better than 98.53% of 68
companies
in the Medical Distribution industry
Industry Median: 3.39
vs TSE:3151: 19.80
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Vital KSK Holdings 5-Year Yield-on-Cost % Related Terms
TSE:3151 vs MCK, CAH, COR: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Vital KSK Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital KSK Holdings 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Vital KSK Holdings's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Vital KSK Holdings (TSE:3151) has a 5-Year Yield-on-Cost % of 19.80 as of Jul. 25, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Vital KSK Holdings and its competitors. This is 85% above median its historical median of 10.69. Over the past decade, Vital KSK Holdings' 5-Year Yield-on-Cost % has ranged from 6.58 to 23.40. According to the industry distribution chart, Vital KSK Holdings ranks #1 out of 68 companies in the Medical Distribution industry, placing it in the top 1.5%.
Is Vital KSK Holdings' 5-Year Yield-on-Cost % too high?
Vital KSK Holdings' current 5-Year Yield-on-Cost % of 19.80 is 85% above median its 10-year median of 10.69. Over the past 10 years, this metric has ranged from a low of 6.58 to a high of 23.40. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.39. Vital KSK Holdings' value of 19.80 is 484.1% above this industry median. Based on the distribution chart, Vital KSK Holdings ranks #1 out of 68 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Vital KSK Holdings has a GF Score™ of 69/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' 5-Year Yield-on-Cost % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Vital KSK Holdings ranks #1 out of 68 companies for 5-Year Yield-on-Cost %. This places Vital KSK Holdings in the top 2% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.39. Vital KSK Holdings' value of 19.80 is 484.1% above this benchmark. Historically, Vital KSK Holdings' own 5-Year Yield-on-Cost % has ranged from 6.58 to 23.40 over the past decade. While the company's 10-year median is 10.69 vs. the industry median of 3.39, Vital KSK Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.39, based on 68 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital KSK Holdings's current 5-Year Yield-on-Cost % of 19.80 is 484.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Vital KSK Holdings and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital KSK Holdings's current 5-Year Yield-on-Cost % is 19.80, which is 85% above median its own 10-year median of 10.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,327.02, compared to a current price of 円1,661.00 — trading 25.2% above its estimated fair value. The current 5-Year Yield-on-Cost % is 19.80, which is 85% above median its 10-year median of 10.69 and 484.1% above the Medical Distribution industry median of 3.39. Vital KSK Holdings' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current 5-Year Yield-on-Cost % is 19.80 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?
Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued.
The current stock price of 円1,661.00 is trading 25.2% above its estimated GF Value™ of 円1,327.02.
GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.
Key valuation signals for TSE:3151:
5-Year Yield-on-Cost %: 19.80 (85% above median its 10-year median of 10.69)
GF Value™: 円1,327.02 vs. price of 円1,661.00 (25.2% above fair value)
Industry Position: 484.1% above the Medical Distribution median (#1 of 68)
No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
69GF Score
Get the complete analysis for TSE:3151
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3151 has been successfully added to your 
